COVID-19 vaccination in Sri Lanka
From Wikipedia, the free encyclopedia
.jpg) A Sri Lankan woman is vaccinated in 2021 as part of the COVAX initiative | |
| Date | 29 January 2021 (2021-01-29) – present |
|---|---|
| Location | Sri Lanka |
| Cause | COVID-19 pandemic in Sri Lanka |
| Organized by | Government of Sri Lanka |
| Outcome |
|
| Part of a series on the |
| COVID-19 pandemic |
|---|
 |
|
|
Medical response |
|
.svg){kind=small} COVID-19 portal |
COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, the Sinopharm BIBP vaccine accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date.[1] The United States donated over 1.5 million Moderna vaccine through COVAX.[2]
Shortages
The Government of Sri Lanka commenced its COVID-19 vaccination program under the COVAX facility with first batch of Oxford–AstraZeneca vaccines arrive in Sri Lanka on 28 January 2021 from the Serum Institute of India. (SII).[3]
By April, with a surge in COVID cases in a third wave of infections, Sri Lanka faced a severe shortage of the Astra-Zeneca vaccine due to an export ban by India.[4] This left majority of the 3.5% of the population that was given the first dose without access to the second.[5] Sri Lanka faced an shortage of Sputnik V vaccine due to a spike of cases in Russia resulting in the manufacturer Gamaleya Research Institute of Epidemiology and Microbiology, focusing on meeting local demand.[6]
Other vaccine supplies
In March 2021, the Sinopharm BIBP vaccine was approved emergency use.[7] In May, the country ordered 14 million doses on top of 1.1 million doses previously donated.[8] By July, Sri Lanka had received 10.7 million doses of the vaccine.[1] In June, local studies in the country showed vaccination with the Sinopharm BIBP vaccine generated seroconversion and antibody responses in individuals to Delta and Beta variants similar to antibody levels seen following a natural infection[9][10]
Phase three
With vaccination of persons above 30 years reaching completion, vaccination of those between 18 and 30 years who did not fall under special categories were started in early September 2021.[11]
Proposed vaccine production
On 27 May State Minister for Pharmaceuticals Channa Jayasumana told reporters Sri Lanka was considering co-production of CoronaVac. It was not clarified if it would handle full production or a fill and finish plant.[12]
Vaccination programme
Vaccines used
Currently, the vaccines approved by government of Sri Lanka for emergency use are:
| Vaccine | Approval | Deployment |
|---|---|---|
| Oxford–AstraZeneca |  Yes |
Yes[3] |
| Sinopharm BIBP | Yes |
Yes[13] |
| Sputnik V | Yes |
Yes[14] |
| Pfizer–BioNTech | Yes |
Yes |
| Moderna | Yes |
Yes |
| Sinovac | Yes |
 No |
Vaccine distribution
Vaccine types were deployed on a geographical and group basis:
- Special groups
- Medical professionals and front line workers: Oxford–AstraZeneca
- Students travelling overseas for studies: Pfizer–BioNTech
- Migrant workers travelling overseas for work: Pfizer–BioNTech
- Fishermen in Mannar: Pfizer–BioNTech
- Geographical
- Western province: Oxford–AstraZeneca, Sinopharm BIBP
- Central province: Sputnik V, Moderna
- Southern province: Oxford–AstraZeneca, Sinopharm BIBP
- North Western province: Oxford–AstraZeneca, Sinopharm BIBP
- Northern province: Sinopharm BIBP
- Eastern province: Sinopharm BIBP
- Sabaragamuwa province: Sinopharm BIBP
- Uva province: Sinopharm BIBP
- North central province: Sinopharm BIBP
Vaccine on order
| Vaccine | Type (technology) | Doses ordered | Manufacturer | Remarks |
|---|---|---|---|---|
| Oxford–AstraZeneca | Viral vector | 8,400,000 |  Serum Institute |
- |
| Sputnik V | Viral vector | 13,000,000 |  R-Pharm |
- |
| Pfizer–BioNTech | RNA | 14,900,000 [15][11] |  Pfizer |
- |
| Sinopharm BIBP | Inactivated virus | 23,000,000[16][8] |  Sinopharm |
- |
References
- 1 2 "Sri Lanka had little choice except China's Sinopharm: Weeratunga". EconomyNext. 29 July 2021. Archived from the original on 29 July 2021. Retrieved 29 July 2021.
- ↑ "U.S. donates over 1.5 million Moderna COVID-19 vaccines to Sri Lanka". usembassy.gov. US Embassy in Sri Lanka. 16 July 2021. Archived from the original on 30 July 2021. Retrieved 30 July 2021.
- 1 2 "First batch of COVID-19 vaccines from the COVAX Facility arrive in Sri Lanka". who.int. Archived from the original on 3 June 2021. Retrieved 2 June 2021.
- ↑ "Sri Lanka's COVID-19 Response: Saving Lives Today, Preparing for Tomorrow". World Bank. Archived from the original on 23 September 2023. Retrieved 10 February 2022.
- ↑ "The Latest: Sri Lanka looks to ease shortage with Sputnik V". independent.co.uk. Archived from the original on 2 June 2021. Retrieved 2 June 2021.
- ↑ "Sputnik V vaccine supply hindered due to spike in Covid cases in Russia". Daily Mirror. Archived from the original on 30 July 2021. Retrieved 30 July 2021.
- ↑ "NMRA approves sinopharm vaccine for emergency use". Colombo Gazette. 19 March 2021. Retrieved 20 March 2021.
- 1 2 "The Latest: Sri Lanka gets 2nd vaccine donation from China". ABC News. Archived from the original on 25 May 2021. Retrieved 28 May 2021.
- ↑ "Tests in Sri Lanka find Sinopharm vaccine very effective". Colombo Gazette. 20 July 2021. Archived from the original on 20 July 2021. Retrieved 21 July 2021.
- ↑ Jeewandara, Chandima; Aberathna, Inoka Sepali; Pushpakumara, Pradeep Dharshana; Kamaladasa, Achala; Guruge, Dinuka; Jayathilaka, Deshni; Gunesekara, Banuri; Tanussiya, Shyrar; Kuruppu, Heshan; Ranasinghe, Thushali; Dayarathne, Shashika (2022). "Immune responses to Sinopharm/ BBIBP-CorV in individuals in Sri Lanka". Immunology. 167 (2): 275–285. doi:10.1111/imm.13536. medRxiv 10.1101/2021.07.15.21260621v1. PMC 11495257. PMID 35758860.
- 1 2 "Govt. aims to complete vaccinating all above 18 by September end". Adaderana. Archived from the original on 19 August 2021. Retrieved 19 August 2021.
- ↑ "Sri Lanka to co-produce Sinovac vaccines: Minister". EconomyNext. 27 May 2021. Archived from the original on 11 June 2021. Retrieved 11 June 2021.
- ↑ "Sri Lanka begins administering Sinopharm vaccines". xinhuanet. Archived from the original on 6 October 2021. Retrieved 2 June 2021.
- ↑ "Sri Lanka rolls out Russia's Sputnik V vaccine". The Hindu. Archived from the original on 11 October 2021. Retrieved 2 June 2021.
- ↑ "Sri Lanka to purchase 900,000 doses of Pfizer-BionTech COVID-19 vaccine in July". economynext.com. Archived from the original on 3 June 2021. Retrieved 2 June 2021.
- ↑ "Sri Lanka eyes 3mn Sinopharm Covid-19 doses to ramp up Coronavirus vaccination drive". economynext.com. Archived from the original on 2 June 2021. Retrieved 2 June 2021.
